Healthcare provider profile · identity verified

Jose Luis Soler, MD

Family Practice · SEFFNER, FL · NPI 1932163961

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	646	201
Levothyroxine Sodium	Levothyroxine Sodium	439	120
Gabapentin	Gabapentin	412	123
Amlodipine Besylate	Amlodipine Besylate	318	100
Fluticasone Propionate	Fluticasone Propionate	304	131
Losartan Potassium	Losartan Potassium	288	93
Lisinopril	Lisinopril	276	89
Omeprazole	Omeprazole	241	72
Baclofen	Baclofen	234	90
Metoprolol Succinate	Metoprolol Succinate	216	61
Metformin Hcl	Metformin Hcl	200	65
Montelukast Sodium	Montelukast Sodium	189	65
Glipizide	Glipizide	178	52
Meloxicam	Meloxicam	168	53
Alendronate Sodium	Alendronate Sodium	166	58
Rosuvastatin Calcium	Rosuvastatin Calcium	164	48
Celecoxib	Celecoxib	161	40
Famotidine	Famotidine	159	49
Tamsulosin Hcl	Tamsulosin Hcl	158	55
Albuterol Sulfate Hfa	Albuterol Sulfate	151	46
Furosemide	Furosemide	142	45
Alprazolam	Alprazolam	138	43
Pantoprazole Sodium	Pantoprazole Sodium	134	51
Metoprolol Tartrate	Metoprolol Tartrate	132	39
Donepezil Hcl	Donepezil Hcl	131	37
Hydrochlorothiazide	Hydrochlorothiazide	112	39
Meclizine Hcl	Meclizine Hcl	112	36
Prednisone	Prednisone	105	84
Memantine Hcl	Memantine Hcl	103	32
Trazodone Hcl	Trazodone Hcl	101	29
Sertraline Hcl	Sertraline Hcl	95	29
Eliquis	Apixaban	91	21
Doxycycline Monohydrate	Doxycycline Monohydrate	89	77
Finasteride	Finasteride	86	29
Simvastatin	Simvastatin	83	28
Lantus	Insulin Glargine,hum.Rec.Anlog	82	17
Carvedilol	Carvedilol	80	22
Methylprednisolone	Methylprednisolone	73	64
Pravastatin Sodium	Pravastatin Sodium	72	26
Pioglitazone Hcl	Pioglitazone Hcl	70	23
Clopidogrel	Clopidogrel Bisulfate	67	20
Vitamin D2	Ergocalciferol (Vitamin D2)	66	27
Buspirone Hcl	Buspirone Hcl	65	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	64	suppressed
Mirtazapine	Mirtazapine	63	15
Duloxetine Hcl	Duloxetine Hcl	61	18
Escitalopram Oxalate	Escitalopram Oxalate	61	17
Tramadol Hcl	Tramadol Hcl	61	22
Azithromycin	Azithromycin	60	43
Sildenafil Citrate	Sildenafil Citrate	59	19
Triamcinolone Acetonide	Triamcinolone Acetonide	56	30
Diclofenac Sodium	Diclofenac Sodium	54	20
Allopurinol	Allopurinol	53	13
Potassium Chloride	Potassium Chloride	49	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	17
Amoxicillin	Amoxicillin	48	44
Spironolactone	Spironolactone	48	13
Enalapril Maleate	Enalapril Maleate	47	13
Jardiance	Empagliflozin	47	12
Trulicity	Dulaglutide	45	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	43	25
Clonazepam	Clonazepam	41	suppressed
Metformin Hcl Er	Metformin Hcl	41	16
Ozempic	Semaglutide	39	suppressed
Pregabalin	Pregabalin	39	11
Ibuprofen	Ibuprofen	38	13
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Hydrocortisone	Hydrocortisone	37	14
Entresto	Sacubitril/Valsartan	36	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	36	suppressed
Sulindac	Sulindac	35	14
Doxazosin Mesylate	Doxazosin Mesylate	34	suppressed
Naproxen	Naproxen	34	11
Novolin N	Insulin Nph Human Isophane	34	suppressed
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	32	suppressed
Synthroid	Levothyroxine Sodium	32	suppressed
Azelastine Hcl	Azelastine Hcl	31	17
Felodipine Er	Felodipine	31	suppressed
Latanoprost	Latanoprost	31	suppressed
Warfarin Sodium	Warfarin Sodium	31	suppressed
Nifedipine Er	Nifedipine	30	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	26
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Methimazole	Methimazole	27	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	27	suppressed
Fenofibrate	Fenofibrate	26	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	23	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	22
Atenolol	Atenolol	22	suppressed
Fluconazole	Fluconazole	22	15
Glimepiride	Glimepiride	22	suppressed
Novolin R	Insulin Regular, Human	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Bumetanide	Bumetanide	21	suppressed
Nabumetone	Nabumetone	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Ibandronate Sodium	Ibandronate Sodium	20	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	20	suppressed
Levofloxacin	Levofloxacin	19	18
Sucralfate	Sucralfate	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Valsartan	Valsartan	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	16
Doxycycline Hyclate	Doxycycline Hyclate	17	14
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	suppressed
Nystatin	Nystatin	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	11
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	16	suppressed
Carisoprodol	Carisoprodol	15	suppressed
Invokana	Canagliflozin	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Rifampin	Rifampin	12	suppressed
Temazepam	Temazepam	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Topiramate	Topiramate	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Estradiol	Estradiol	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error